The modulatory effect of CA1 GABAb receptors on ketamine-induced spatial and non-spatial novelty detection deficits with respect to Ca2+

Neuroscience

Volumn 305, Issue , 2015, Pages 157-168

  Khanegheini, A ^a   Nasehi, M ^a,b   Zarrindast, M R ^a,b,c,d,e  

^a INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

CA1; GABAb; Ketamine; Spatial memory

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; CALCIUM ION; KETAMINE; 1-(2-(3-(4-METHOXYPHENYL)PROPOXY)-4-METHOXYPHENYLETHYL)-1H-IMIDAZOLE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; BACLOFEN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; IMIDAZOLE DERIVATIVE; PHACLOFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE ACTIVITY; HIPPOCAMPAL CA1 REGION; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SPATIAL MEMORY; TASK PERFORMANCE; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; EXPLORATORY BEHAVIOR; METABOLISM; PATHOLOGY; PERCEPTIVE DISCRIMINATION; SPATIAL BEHAVIOR;

ANALYSIS OF VARIANCE; ANIMALS; BACLOFEN; CA1 REGION, HIPPOCAMPAL; CALCIUM; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; GABA ANTAGONISTS; IMIDAZOLES; KETAMINE; MALE; MEMORY DISORDERS; MICE; RECEPTORS, GABA-A; SIGNAL DETECTION, PSYCHOLOGICAL; SPATIAL PROCESSING;

EID: 84954444429     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.07.083     Document Type: Article

References (114)

1. Adriani W., Sargolini F., Coccurello R., Oliverio A., Mele A. Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice. Psychopharmacology 2000, 150:67-76.
2. Aguado L., Antonio A.S., Pérez L., Valle Rd., Gómez J. Effects of the NMDA receptor antagonist ketamine on flavor memory: conditioned aversion, latent inhibition, and habituation of neophobia. Behav Neural Biol 1994, 61:271-281.
3. Amaral O.B., Luft T., Cammarota M., Izquierdo I., Roesler R. Temporary inactivation of the dorsal hippocampus induces a transient impairment in retrieval of aversive memory. Behav Brain Res 2007, 180:113-118.
4. Angulo M.C., Le Meur K., Kozlov A.S., Charpak S., Audinat E. GABA, a forgotten gliotransmitter. Prog Neurobiol 2008, 86:297-303.
5. Azkue J.J., Liu X.-G., Zimmermann M., Sandkühler J. Induction of long-term potentiation of C fibre-evoked spinal field potentials requires recruitment of group I, but not group II/III metabotropic glutamate receptors. Pain 2003, 106:373-379.
6. Barkus C., McHugh S.B., Sprengel R., Seeburg P.H., Rawlins J.N.P., Bannerman D.M. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol 2010, 626:49-56.
7. Bashir ZI, Bortolotto ZA, Davies CH, Berretta N, Irving AJ, Seal AJ, Henley JM, Jane DE, Watkins JC, Collingridge GL (1993) Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors.
8. Benarroch E.E. GABAB receptors Structure, functions, and clinical implications. Neurology 2012, 78:578-584.
9. Benke D., Zemoura K., Maier P.J. Modulation of cell surface GABAB receptors by desensitization, trafficking and regulated degradation. World J Biol Chem 2012, 3:61.
10. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
11. Blundon J.A., Zakharenko S.S. Dissecting the components of long-term potentiation. The Neuroscientist 2008, 14:598-608.
12. Bowery N. GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol 1993, 33:109-147.
13. Castellano C., McGaugh J.L. Effects of post-training bicuculline and muscimol on retention: lack of state dependency. Behav Neural Biol 1990, 54:156-164.
14. Castellano C., Cestari V., Ciamei A. NMDA receptors and learning and memory processes. Curr Drug Targets 2001, 2:273-283.
15. B receptors modulate NMDA receptor calcium signals in dendritic spines. Neuron 2010, 66:101-113.
16. Chapouthier G. From the search for a molecular code of memory to the role of neurotransmitters: a historical perspective. Neural Plast 2004, 11:151-158.
17. Chapouthier G., Venault P. GABA-A receptor complex and memory processes. Curr Top Med Chem 2002, 2:841-851.
18. Chen L., Boyes J., Yung W.H., Bolam J.P. Subcellular localization of GABAB receptor subunits in rat globus pallidus. J Comp Neurol 2004, 474:340-352.
19. B receptor subunits in organotypic hippocampal slice cultures. Neuropharmacology 2009, 56:1088-1096.
20. Collingridge G., Bliss T. Memories of NMDA receptors and LTP. Trends Neurosci 1995, 18:54-56.
21. Cui Y., Costa R.M., Murphy G.G., Elgersma Y., Zhu Y., Gutmann D.H., Parada L.F., Mody I., Silva A.J. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 2008, 135:549-560.
22. Davies CH, Starkey SJ, Pozza MF, Collingridge GL (1991) GABAB autoreceptors regulate the induction of LTP.
23. Davis S.F., Linn C.L. Activation of NMDA receptors linked to modulation of voltage-gated ion channels and functional implications. Am J Physiol - Cell Physiol 2003, 284:C757-C768.
24. Duncan G.E., Moy S.S., Knapp D.J., Mueller R.A., Breese G.R. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 1998, 787:181-190.
25. Errington M., Lynch M., Bliss T. Long-term potentiation in the dentate gyrus: induction and increased glutamate release are blocked by D (-) aminophosphonovalerate. Neuroscience 1987, 20:279-284.
26. Farr S.A., Flood J.F., Morley J.E. The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus. Neurobiol Learn Mem 2000, 73:150-167.
27. Freund T.F., Buzsáki G. Interneurons of the hippocampus. Hippocampus 1996, 6:347-470.
28. B receptor antagonist in clinical trials. Biochem Pharmacol 2004, 68:1479-1487.
29. Gandal M., Sisti J., Klook K., Ortinski P., Leitman V., Liang Y., Thieu T., Anderson R., Pierce R., Jonak G. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl Psych 2012, 2:e142.
30. Gerber G., Youn D.-H., Hsu C., Isaev D., Randić M. Spinal dorsal horn synaptic plasticity: involvement of group I metabotropic glutamate receptors. Prog Brain Res 2000, 129:115-134.
31. Gerlai R., McNamara A. Anesthesia induced retrograde amnesia is ameliorated by ephrinA5-IgG in mice: EphA receptor tyrosine kinases are involved in mammalian memory. Behav Brain Res 2000, 108:133-143.
32. Getova D., Bowery N. The modulatory effects of high affinity GABAB receptor antagonists in an active avoidance learning paradigm in rats. Psychopharmacology 1998, 137:369-373.
33. Greene R. Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†. Hippocampus 2001, 11:569-577.
34. Guetg N., Aziz S.A., Holbro N., Turecek R., Rose T., Seddik R., Gassmann M., Moes S., Jenoe P., Oertner T.G. NMDA receptor-dependent GABAB receptor internalization via CaMKII phosphorylation of serine 867 in GABAB1. Proc Natl Acad Sci 2010, 107:13924-13929.
35. Guimaraes F., Carobrez A., De Aguiar J., GraeffF. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology 1991, 103:91-94.
36. Heinke B., Sandkühler J. Signal transduction pathways of group I metabotropic glutamate receptor-induced long-term depression at sensory spinal synapses. Pain 2005, 118:145-154.
37. Hosford D.A., Clark S., Cao Z., Wilson W., F-h Lin., Morrisett R.A., Huin A. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science 1992, 257:398-401.
38. Hrabetova S., Charlton Sacktor T. Long-term potentiation and long-term depression are induced through pharmacologically distinct NMDA receptors. Neurosci Lett 1997, 226:107-110.
39. Huntley G.W., Vickers J.C., Morrison J.H. Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease. Trends Neurosci 1994, 17:536-543.
40. Irifune M., Shimizu T., Nomoto M., Fukuda T. Ketamine-induced anesthesia involves the N-methyl-d-aspartate receptor-channel complex in mice. Brain Res 1992, 596:1-9.
41. Irifune M., Sato T., Kamata Y., Nishikawa T., Dohi T., Kawahara M. Evidence for GABAA receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg 2000, 91:230-236.
42. Jamali-Raeufy N., Nasehi M., Zarrindast M.R. Influence of N-methyl D-aspartate receptor mechanism on WIN55, 212-2-induced amnesia in rat dorsal hippocampus. Behav Pharmacol 2011, 22:645-654.
43. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20:201-225.
44. Kew J.N., Kemp J.A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 2005, 179:4-29.
45. Khakpai F., Nasehi M., Haeri-Rohani A., Eidi A., Zarrindast M.R. Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum. Behav Brain Res 2012, 231:1-10.
46. Kleinschmidt A., Bear M.F., Singer W. Blockade of" NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex. Science 1987, 238:355-358.
47. Kleschevnikov A.M., Belichenko P.V., Faizi M., Jacobs L.F., Htun K., Shamloo M., Mobley W.C. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. J Neurosci 2012, 32:9217-9227.
48. Koek W., Woods J.H., Ornstein P. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats. Psychopharmacology 1987, 91:297-304.
49. Lacaille J.-C., Schwartzkroin P. Stratum lacunosum-moleculare interneurons of hippocampal CA1 region. II. Intrasomatic and intradendritic recordings of local circuit synaptic interactions. J Neurosci 1988, 8:1411-1424.
50. Lalonde R., Joyal C.C. Effects of ketamine and l-glutamic acid diethyl ester on spatial and nonspatial learning tasks in rats. Pharmacol Biochem Behav 1993, 44:539-545.
51. Li F., Tsien J.Z. Memory and the NMDA receptors. N Engl J Med 2009, 361:302.
52. Liu J., Moghaddam B. Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation. J Pharmacol Exp Ther 1995, 274:1209-1215.
53. Luján R., Shigemoto R., Kulik A., Juiz J.M. Localization of the GABAB receptor 1a/b subunit relative to glutamatergic synapses in the dorsal cochlear nucleus of the rat. J Comp Neurol 2004, 475:36-46.
54. Macey D.J., Froestl W., Koob G.F., Markou A. Both GABA(B) receptor agonist and antagonists decreased brain stimulation reward in the rat. Neuropharmacology 2001, 40:676-685.
55. Maier P.J., Marin I., Grampp T., Sommer A., Benke D. Sustained glutamate receptor activation down-regulates GABAB receptors by shifting the balance from recycling to lysosomal degradation. J Biol Chem 2010, 285:35606-35614.
56. Martinez J.L., Derrick B.E. Long-term potentiation and learning. Annu Rev Psychol 1996, 47:173-203.
57. McDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990, 15:41-70.
58. Merritt J.E., Armstrong W., Benham C., Hallam T., Jacob R., Jaxa-Chamiec A., Leigh B., McCarthy S., Moores K., Rink T. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 1990, 271:515-522.
59. Mickley G.A., Remmers-Roeber D.R., Crouse C., Peluso R. Ketamine blocks a taste recognition memory in fetal rats. Pharmacol Biochem Behav 2000, 67:575-581.
60. Miwa A., Robinson H.P., Kawai N. Presynaptic glutamate receptors depress inhibitory postsynaptic transmission in lobster neuromuscular synapse. J Neurophysiol 1993, 70. 1159-1159.
61. Mizuno M., Yamada K., Maekawa N., Saito K., Seishima M., Nabeshima T. CREB phosphorylation as a molecular marker of memory processing in the hippocampus for spatial learning. Behav Brain Res 2002, 133:135-141.
62. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997, 17:2921-2927.
63. Mohammadi M., Nasehi M., Zarrindast M.R. Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala. Behav Brain Res 2015, 280:36-44.
64. Mondadori C., Preiswerk G., Jaekel J. Treatment with a GABAB receptor blocker improves the cognitive performance of mice, rats and rhesus monkeys. Pharmacol Comm 1992, 2:93-97.
65. B blocker improves the cognitive performance of mice, rats, and rhesus monkeys. Behav Neural Biol 1993, 60:62-68.
66. Monfort P., Erceg S., Piedrafita B., Llansola M., Felipo V. Chronic liver failure in rats impairs glutamatergic synaptic transmission and long-term potentiation in hippocampus and learning ability. Eur J Neurosci 2007, 25:2103-2111.
67. Morris R. Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-d-aspartate receptor antagonist AP5. J Neurosci 1989, 9:3040-3057.
68. Morris R, Anderson E, Lynch Ga, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5.
69. Morrisett R., Mott D., Lewis D., Swartzwelder H., Wilson W. GABAB-receptor-mediated inhibition of the N-methyl-d-aspartate component of synaptic transmission in the rat hippocampus. J Neurosci 1991, 11:203-209.
70. Moser M.-B., Moser E.I. Distributed encoding and retrieval of spatial memory in the hippocampus. J Neurosci 1998, 18:7535-7542.
71. Nadlewska A., Car H., Wiśniewska R., Hoły Z., Wiśniewski K. Behavioral effects of D-AP7 in rats subjected to experimental hypoxia. Pol J Pharmacol 2002, 55:337-344.
72. Naghdi N., Majlessi N., Bozorgmehr T. The effect of intrahippocampal injection of testosterone enanthate (an androgen receptor agonist) and anisomycin (protein synthesis inhibitor) on spatial learning and memory in adult, male rats. Behav Brain Res 2005, 156:263-268.
73. B receptor antagonist CGP36742 improves learned helplessness in rats. Eur J Pharmacol 1999, 381:1-7.
74. Nakao S., Nagata A., Miyamoto E., Masuzawa M., Murayama T., Shingu K. Inhibitory effect of propofol on ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABAA receptor activation. Acta Anaesthesiol Scand 2003, 47:284-290.
75. Nasehi M., SharifiS., Zarrindast M.R. Involvement of the cholinergic system of CA1 on harmane-induced amnesia in the step-down passive avoidance test. J Psychopharmacol 2012, 26:1151-1161.
76. Nasehi M., Amin-Yavari S., Ebrahimi-Ghiri M., Torabi-Nami M., Zarrindast M.R. The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in step-down passive avoidance learning task. Eur Neuropsychopharmacol 2015, 25:557-565.
77. Nasehi M., Ketabchi M., Khakpai F., Zarrindast M.R. The effect of CA1 dopaminergic system in harmaline-induced amnesia. Neuroscience 2015, 285:47-59.
78. Nasehi M., Sharaf-Dolgari E., Ebrahimi-Ghiri M., Zarrindast M.R. The hippocampal NMDA receptors may be involved in acquisition, but not expression of ACPA-induced place preference. Prog Neuropsychopharmacol Biol Psychiatry 2015, 63:83-90.
79. Nasehi M., Tabatabaie M., Khakpai F., Zarrindast M.R. The effects of CA1 5HT4 receptors in MK801-induced amnesia and hyperlocomotion. Neurosci Lett 2015, 587:73-78.
80. Naseri M.H., Hesami-Tackallou S., Torabi-Nami M., Zarrindast M.R., Nasehi M. Involvement of the CA1 GABAA receptors in MK-801-induced anxiolytic-like effects: an isobologram analysis. Behav Pharmacol 2014, 25:197-205.
81. Nitz D., McNaughton B. Differential modulation of CA1 and dentate gyrus interneurons during exploration of novel environments. J Neurophysiol 2004, 91:863-872.
82. B receptor antagonists on GABAergic transmission in vivo and in vitro. Eur J Pharmacol 1993, 233:179-186.
83. Padovan C.M., Del Bel E.A., Guimarães F.S. Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: influence of restraint stress. Pharmacol Biochem Behav 2000, 67:325-330.
84. Paulsen O., Moser E. A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci 1998, 21:273-278.
85. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinates 2001, Academic, San Diego.
86. Pitsikas N., Boultadakis A., Sakellaridis N. Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory. Neuroscience 2008, 154:454-460.
87. Pourmotabbed A., Motamedi F., Fathollahi Y., Mansouri F.A., Semnanian S. Involvement of NMDA receptors and voltage-dependent calcium channels on augmentation of long-term potentiation in hippocampal CA1 area of morphine dependent rats. Brain Res 1998, 804:125-134.
88. Riaza Bermudo-Soriano C., Perez-Rodriguez M.M., Vaquero-Lorenzo C., Baca-Garcia E. New perspectives in glutamate and anxiety. Pharmacol Biochem Behav 2012, 100:752-774.
89. Richter-Levin G., Errington M., Maegawa H., Bliss T. Activation of metabotropic glutamate receptors is necessary for long-term potentiation in the dentate gyrus and for spatial learning. Neuropharmacology 1994, 33:853-857.
90. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 2003, 140:1-47.
91. Roullet P., Ammassari-Teule M., Mele A. Involvement of glutamatergic and dopaminergic systems in the reactivity of mice to spatial and non-spatial change. Psychopharmacology 1996, 126:55-61.
92. Roullet P., Sargolini F., Oliverio A., Mele A. NMDA and AMPA antagonist infusions into the ventral striatum impair different steps of spatial information processing in a nonassociative task in mice. J Neurosci 2001, 21:2143-2149.
93. Rowland L.M., Astur R.S., Jung R.E., Bustillo J.R., Lauriello J., Yeo R.A. Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 2005, 30:633-639.
94. Rowley N.M., Madsen K.K., Schousboe A., Steve White H. Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int 2012, 61:546-558.
95. B receptors to control rhythmic hippocampal activity. Neuron 2000, 25:673-681.
96. Silvers J.M., Tokunaga S., Berry R.B., White A.M., Matthews D.B. Impairments in spatial learning and memory: ethanol, allopregnanolone, and the hippocampus. Brain Res Rev 2003, 43:275-284.
97. Smirnova T., Stinnakre J., Mallet J. Characterization of a presynaptic glutamate receptor. Science 1993, 262:430-433.
98. Sonntag W.E., Bennett S.A., Khan A.S., Thornton P.L., Xu X., Ingram R.L., Brunso-Bechtold J.K. Age and insulin-like growth factor-1 modulate N-methyl-d-aspartate receptor subtype expression in rats. Brain Res Bull 2000, 51:331-338.
99. Stanley B., Urstadt K., Charles J., Kee T. Glutamate and GABA in lateral hypothalamic mechanisms controlling food intake. Physiol Behav 2011, 104:40-46.
100. B receptor-mediated presynaptic inhibition of glutamatergic transmission in the inferior colliculus. Neurosci Lett 2006, 399:151-156.
101. Svensson T.H. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Rev 2000, 31:320-329.
102. Tonkiss J., Rawlins J. The competitive NMDA antagonist AP5, but not the non-competitive antagonist MK801, induces a delay-related impairment in spatial working memory in rats. Exp Brain Res 1991, 85:349-358.
103. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 1990, 185:1-10.
104. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 2002, 42:165-179.
105. Uchihashi Y., Kuribara H., Isa Y., Morita T., Sato T. The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism. Psychopharmacology 1994, 116:40-44.
106. Vargas K.J., Terunuma M., Tello J.A., Pangalos M.N., Moss S.J., Couve A. The availability of surface GABAB receptors is independent of γ-aminobutyric acid but controlled by glutamate in central neurons. J Biol Chem 2008, 283:24641-24648.
107. B receptor variants. Neuron 2006, 50:589-601.
108. Wang J.K., Thukral V. Presynaptic NMDA receptors display physiological characteristics of homomeric complexes of NR1 subunits that contain the exon 5 insert in the N-terminal domain. J Neurochem 1996, 66:865-868.
109. B receptors in the mouse spinal cord. Life Sci 2000, 68:719-725.
110. Yamada K., Yu B., Gallagher J.P. Different subtypes of GABAB receptors are present at pre- and postsynaptic sites within the rat dorsolateral septal nucleus. J Neurophysiol 1999, 81:2875-2883.
111. Yamakura T., Chavez-Noriega L.E., Harris R.A. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine. Anesthesiology 2000, 92:1144-1153.
112. 2+. Neural Plast 2013.
113. YousefiB., Nasehi M., Khakpai F., Zarrindast M.R. Possible interaction of cholinergic and GABAergic systems between MS and CA1 upon memory acquisition in rats. Behav Brain Res 2012, 235:231-243.
114. YousefiB., Farjad M., Nasehi M., Zarrindast M.R. Involvement of the CA1 GABAA receptors in ACPA-induced impairment of spatial and non-spatial novelty detection in mice. Neurobiol Learn Mem 2013, 100:32-40.